Profiel
Joan Mannick was the founder of resTORbio, Inc. which was founded in 2016, where she held the title of Chief Medical Officer from 2017 to 2020.
She is also the founder of Tornado Therapeutics, Inc. Dr. Mannick's former jobs include being the Medical Director at Genzyme Corp.
from 2007 to 2010 and the Executive Director-New Indications Discovery Unit at Novartis Institutes of Biomedical Research from 2010 to 2017.
Dr. Mannick received her doctorate from Harvard Medical School and her undergraduate degree from Harvard College.
Actieve functies van Joan Mannick
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van Joan Mannick
| Bedrijven | Functie | Einde |
|---|---|---|
| ADICET BIO, INC. | Oprichter | 14-09-2020 |
Novartis Institutes of Biomedical Research
 Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Corporate Officer/Principal | 01-03-2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2010 |
Opleiding van Joan Mannick
| Harvard College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
Novartis Institutes of Biomedical Research
Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
